FDA Explains Trial Expectations for Gastroparesis Drugs

Drug Industry Daily
A A
Drugmakers developing treatments for diabetic and idiopathic gastroparesis should study those patient populations in separate trials, the FDA says.

To View This Article:

Login

Subscribe To Drug Industry Daily